Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. MIRM
MIRM logo

MIRM

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

MIRM News

Vertex and Mirum Pharmaceuticals Market Dynamics

1d agoNASDAQ.COM

Vertex and Mirum: Biotech Investment Opportunities

1d agoFool

Mirum Pharmaceuticals: A Rising Star in Biotech

Apr 13 2026Fool

Mirum Pharmaceuticals to Report Four Key Clinical Readouts in Next 18 Months

Apr 13 2026NASDAQ.COM

ClearBridge SMID Cap Growth Strategy Outperforms Benchmark in Q1 2026

Apr 09 2026seekingalpha

Mirum (MIRM) Q1 2025 Earnings Call Transcript

Apr 01 2026NASDAQ.COM

Mirum Pharmaceuticals Grants Stock Options and RSUs to New Employees

Mar 12 2026Newsfilter

Mirum Pharmaceuticals Reports Strong Q4 2025 Earnings and 2026 Guidance

Feb 26 2026seekingalpha

Mirum (MIRM) Q4 2025 Earnings Call Transcript

Feb 25 2026NASDAQ.COM

Mirum Pharmaceuticals Reports Q4 Revenue Growth of 49.8%

Feb 25 2026seekingalpha

Penn Capital Increases Stake in ACM Research, Inc.

Feb 25 2026Fool

Penn Capital Initiates Position in ACM Research with $17.21 Million Investment

Feb 25 2026NASDAQ.COM

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences

Feb 23 2026Yahoo Finance

Mirum Pharmaceuticals Grants Stock Awards to New Employees

Feb 11 2026Newsfilter

Mirum Pharmaceuticals Grants Stock Awards to New Employees

Feb 11 2026Businesswire

Warning Signs for Overbought Healthcare Stocks

Feb 02 2026Benzinga